SB Drug Discovery, an industry leading specialist contract research organization and part of the Sygnature Discovery group, is pleased to announce the expansion of its operations with a new, dedicated screening facility at the Fleming Pavilion within the West of Scotland Science Park. The move aims to further enhance the efficiency and capacity of our screening operations currently located within the company’s Telford Pavilion facility.
Renowned globally for it target expertise and cell biology capabilities, supporting novel drug discovery from target validation to hit identification and lead optimization. SB Drug Discovery’s expansion reflects its commitment to leveraging the latest technologies delivering fast, reliable and robust data, customized to meet the specific needs of each of its partners.
We are extremely excited to be opening our new Fleming Laboratory on the West of Scotland Science Park. The labs have been built to the highest specification and are ideally located next to our existing Telford Labs to ensure seamless collaboration between the respective drug discovery teams. The new laboratories provide us with additional space to allow us to continue our rapid expansion plans and meet the growing demand for our services, while also ensuring we continue to provide the highest level of service to our global customers.
